We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage

Australian Public Assessment Report

AusPAR

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 633.59 KB]

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 525.58 KB]

Attachment: Product Information: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 339.79 KB]

Attachment: Product Information: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 103.26 KB]

Attachment: Extract from the Clinical Evaluation Report: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 902.78 KB]

Attachment: Extract from the Clinical Evaluation Report: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 1.8 MB]

Device/Product Name

FluQuadri, FluQuadri Junior

Active ingredients

Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage

AusPAR Date

6 February 2015

Published

20 March 2015

Submission Number

PM-2013-02401-1-2

Submission Type

New biological entity

Decision

Approved